Celsus Laboratories Inc Celsus Laboratories Heparin Lithium Lyophilized; Lithium Heparin for use in blood collection tube devices and in vitro diagnostic devices. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Celsus Laboratories Heparin Lithium Lyophilized; Lithium Heparin for use in blood collection tube devices and in vitro diagnostic devices.
Brand
Celsus Laboratories Inc
Lot Codes / Batch Numbers
Lot# HL-31707, HL-31807, HL-32708, HL-32808 & HL-32908
Products Sold
Lot# HL-31707, HL-31807, HL-32708, HL-32808 & HL-32908
Celsus Laboratories Inc is recalling Celsus Laboratories Heparin Lithium Lyophilized; Lithium Heparin for use in blood collection tube de due to Contamination: The firm learned that up to 2.2% oversulfated chondroitin was found in a batch of crude heparin they received from their supplier.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Contamination: The firm learned that up to 2.2% oversulfated chondroitin was found in a batch of crude heparin they received from their supplier.
Recommended Action
Per FDA guidance
Celsus notified their customers by e-mail on April 24, 2008, explaining that oversulfated chondroitin was found in a batch of crude heparin they received from their supplier. Celsus recommended the device manufacturers quarantine material from the specified lots.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
IN, NE, NJ, OH, PR
Page updated: Jan 10, 2026